Estrogen receptor modulators

Details for Australian Patent Application No. 2005314230 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Sperbeck, Donald M.; Wildonger, Kenneth J.; Meng, Dongfang; Greenlee, Mark L.

Agent Spruson & Ferguson

Pub. Number AU-B-2005314230

PCT Pub. Number WO2006/062876

Priority 60/634,785 09.12.04 US

Filing date 5 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 19 May 2011

International Classifications

C07D 403/02 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/062876 Priority application(s): WO2006/062876

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

19 May 2011 Application Accepted

  Published as AU-B-2005314230

15 September 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314231-Protein subcellular localization assays using split fluorescent proteins

2005314226-Materials and methods for treating and managing plaque disease